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Introduction: NLRP3 plays a role in sensing various pathogen components or stresses in the innate immune system.
Once activated, NLRP3 associates with apoptosis-associated speck-like protein containing a caspase recruitment domain
(ASC) and procaspase-1 to form a large protein complex termed inflammasome. Although some investigators have
proposed a model of NLRP3-inflammasome containing an adaptor protein caspase recruitment domain-containing
protein 8 (CARD8), the role of this molecule remains obscure. This study aimed to clarify the interaction between CARD8
and wild-type NLRP3 as well as mutant forms of NLRP3 linked with cryopyrin-associated periodic syndromes (CAPS).
Methods: In here HEK293 expression system, cells were transfected with the cDNAs for inflammasome components. Also
used were peripheral blood mononuclear cells (PBMCs) and human monocyte-derived macrophages (HMDMs) from
healthy volunteers. The interaction of CARD8 and NLRP3 was studied by immunoprecipitation. The effect of CARD8
expression on IL-1β secretion was assessed by ELISA. CARD8 knockdown experiments were carried out by transfection of
the specific siRNA into HMDMs.
Results: In HEK293 cells, CARD8 interacted with wild-type NLRP3, but not with CAPS-associated mutant NLRP3. CARD8
significantly reduced IL-1β secretion from cells transfected with wild-type NLRP3, but not if they were transfected with
mutant NLRP3. In addition, association of endogenously expressed CARD8 with NLRP3 was confirmed in resting PBMCs,
and CARD8 knockdown resulted in higher amount of IL-1β secretion from HMDMs.
Conclusions: Until specific stimuli activate NLRP3, CARD8 holds NLRP3, and is supposed to prevent activation by subtle
stimuli. However, CAPS-associated mutant NLRP3 is unable to bind with CARD8, which might be relevant to the
pathogenesis of CAPS.Introduction
The NLR (nucleotide binding oligomerization domain-like
receptor) protein family plays a role as an intracellular
sensor for pathogens and cell injury by detecting con-
served structures, such as pathogen-associated molecular
patterns (PAMPs) and damage-associated molecular pat-
terns (DAMPs) [1,2]. NLRP3, a member of the NLR, is a
cytoplasmic protein expressed predominantly in mono-
cytes and macrophages, and forms a caspase-1 activating
multiprotein complex termed inflammasome with other* Correspondence: tetsuo.kubota.mtec@tmd.ac.jp
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reproduction in any medium, provided the orproteins, including an adaptor protein ASC (apoptosis-as-
sociated speck-like protein containing a caspase recruit-
ment domain (CARD)) and procaspase-1 [3,4]. The
NLRP3 is composed of three domains referred to as pyrin
domain (PYD) at the N-terminus, leucine-rich repeats
(LRRs) at the C-terminus, and nucleotide binding-
oligomerization domain (NOD) in the middle. When
PAMPs or DAMPs are recognized by the LRRs, NLRP3
oligomerizes by self-association through the NOD, and
binds with ASC via their PYD domains [5,6]. ASC and
procaspase-1 bind with each other through their CARD
[7,8], which leads to the assembly and autocleavage of the
procaspase-1 to produce active caspase-1. Then caspase-1This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the extracellular space [9].
Mutations in the cold-induced autoinflammatory
syndrome 1 (CIAS1) gene encoding NLRP3 result in
cryopyrin-associated periodic syndromes (CAPS) character-
ized by recurrent episodes of systemic inflammatory attacks
in the absence of infection or autoimmune diseases [10].
CAPS include three clinical entities: familial cold autoin-
flammatory syndrome (FCAS), Muckle-Wells syndrome
(MWS) and chronic infantile neurologic cutaneous articular
syndrome (CINCA). The mildest form, FCAS, presents
with a cold-induced urticarial rash, fever and arthralgia.
CINCA, the most severe form of CAPS, includes neonatal-
onset high fever, aseptic meningitis, sensory hearing loss,
papilledema, arthritis with bone overgrowth and secondary
amyloidosis. MWS is the intermediate phenotype, and over-
lapping cases between FCAS and MWS, or MWS and
CINCA exist as well. More than 50 CAPS-associated mis-
sense mutations have been reported and, of note, most of
them are clustered in the NOD domain of NLRP3 [11]. As
for the mechanism by which those mutations activate
NLRP3 leading to autoinflammation, Lee et al. have re-
cently noticed the role of the calcium-sensing receptor that
regulates NLRP3 inflammasome through Ca2+ and cAMP
[12], but other mechanisms might be contributed as well.
Caspase recruitment domain-containing protein 8
(CARD8), also called tumor-up-regulated CARD-containing
antagonist of caspase nine (TUCAN) or CARD inhibitor
of NF-κB-activating ligands (Cardinal), is a member of
the CARD family, and is composed of an N-terminal
function to find (FIIND) domain and a C-terminal CARD
domain. In a pioneering study by Razmara et al. [13],
CARD8 was shown to interact physically with caspase-1
through the CARD-CARD homophilic interaction and to
negatively regulate activation of caspase-1. On the other
hand, Agostini et al. [3] showed an interaction between
the FIIND domain of CARD8 and the NOD domain of
NLRP3, and they proposed a model in which NLRP3
inflammasome consists of a complex of NLRP3, ASC,
caspase-1 and CARD8. Subsequently, some review articles
adopted the model of an NLRP3 inflammasome including
CARD8 [14-16] while others excluded CARD8 [17-19].
Thus, the association of CARD8 protein with NLRP3 and
its function in the inflammasome remain obscure.
Here, we show that CARD8 plays a role as a negative
regulator of NLRP3 inflammasome through its binding
with NLRP3. CAPS-associated mutant NLRP3 was, how-
ever, unable to bind to CARD8.
Methods
cDNA cloning of inflammasome components
The study protocols using human blood cells were ap-
proved by the Medical Research Ethics Committee for
Genetic Research, Tokyo Medical and Dental University.Blood samples were obtained from healthy volunteers
after obtaining written informed consent, and we did
not use samples from patients in this study. RNA was
isolated from peripheral blood leukocytes by the acid
guanidinium thiocyanate-phenol-chloroform method
[20]. cDNA was synthesized from total RNA with Super-
Script III reverse transcriptase (Invitrogen, Carlsbad, CA,
USA) using random hexamer as a primer. The entire cod-
ing sequence of NLRP3, ASC, procaspse-1, proIL-1β and
CARD8 (the T48 isoform, amino acids 1 to 431), truncated
coding sequences of CARD8 (the FIIND domain, amino
acids 1 to 346, or the CARD domain, amino acids 321 to
431) were amplified by PCR using modified PCR primers
based on the cDNA sequences from GeneBank (NLRP3,
AF410477; ASC, AB023416; procaspse-1, M87507; proIL-
1β, BC008678; and CARD8, AF322184). The sequences
were confirmed with an ABI Prism 3100 Genetic
Analyzer (Applied Biosystems, Foster City, CA, USA).
The C-terminus Flag (−DYKDDDDK), GFP, and DsRed
(Clontech, Palo Alto, CA, USA) tags were used to
generate fusion proteins. cDNAs of proIL-1β, ASC
and fluorescent fusion proteins were subcloned into the
pTargeT vector (Promega, Mannheim, Germany). NLRP3,
NLRP3-Flag, CARD8, CARD8-Flag, FIIND-Flag, CARD-
Flag and procasapse-1 cDNAs were subcloned into the
pcDNA3.1 vector (Invitrogen).
Polymorphism of CARD8
DNA samples were collected from healthy Japanese donors
using Puregene (Gentra, Big Lake, MN, USA), and the
CARD8 was amplified by PCR using the following primers:
sense: 5′-GATGGAGTCGTAGGGGCCTGAG-3′ and
antisense: 5′-CTCCCTCATCAGGGGCTTCACG-3′. c.30
T > A (rs2043211) variant was detected by sequencing.
Immunoprecipitation of transient transfectants
HEK293 cells were provided by the RIKEN BRC (Tsukuba,
Japan) through the National Bio-Resource Project of the
Ministry of Education, Culture, Sports, Science, and Tech-
nology (MEXT) Japan. The cells were cultured in DMEM
supplemented with 10% heat-inactivated fetal bovine
serum, and transfected with expression plasmids pcDNA
or pTargeT using Lipofectamine LTX (Invitrogen) accord-
ing to the manufacturer’s protocol. At 24 hours after
transfection, cells were lysed with ice-cold lysis buffer
(50 mM Tris-HCl, 150 mM KCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, and 1 mM phenylmethylsulfonyl
fluoride (PMSF), pH 8.0) and solubilized by a sonicator.
The cell lysates were clarified by centrifugation for 10 mi-
nutes at 16,000 g and incubated for 60 minutes at 4°C with
Anti-Flag M2 affinity gel (Sigma, St Louis, MO, USA).
The gels were washed four times with lysis buffer and
the final precipitates were subjected to Western blotting
analysis using the following antibodies: anti-FLAG
Ito et al. Arthritis Research & Therapy 2014, 16:R52 Page 3 of 11
http://arthritis-research.com/content/16/1/R52(Sigma), anti-CARD8 (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), anti-NLRP3 (nalpy3-b, Abcam,
Cambridge, UK), anti-ASC (MBL, Nagoya, Japan), anti-
caspase-1 (Santa Cruz Biotechnology), anti-GAPDH
(Sigma), anti-IL-1β (Santa Cruz Biotechnology), and
anti-cleaved IL-1β (Cell Signaling Technology, Beverly,
MA, USA).
Determination of IL-1β secretion from HEK293 cells
Cells were plated on 12-well plates and transfected with
cDNAs. At 24 hours after transfection, supernatants were
replaced with fresh medium and cells were incubated for
another 24 hours. Then, the second supernatants and pel-
lets were subjected to ELISA and Western blotting, respect-
ively. ELISA was performed using Human IL-1β/IL-1 F2
Immunoassay ELISA Kit (R&D Systems, Minneapolis, MN,
USA). In some experiments, secreted IL-1β during the two-
hour incubation in serum-free medium (Opti-MEM, Gibco,
Carlsbad, CA, USA), with which supernatants were re-
placed at 24 hours after transfection, was detected by
Western blotting as well.
Quantification of specks
HEK293 cells were plated on multi-well glass bottom
dishes (Matsunami, Kishiwada, Japan) and transfected
with the plasmids by lipofection. Twenty-four hours
later, fluorescent images were obtained using a confocal
laser scanning microscope FV500 (Olympus, Tokyo,
Japan), and the percentage of speck-positive cells was
calculated as the number of speck-positive cells divided
by the total number of transfected cells.
Immunoprecipitation of endogenous proteins
Peripheral blood mononuclear cells (PBMCs, 1 × 107
cells/6 cm dish) from healthy volunteers were cultured in
RPMI-1640 medium supplemented with 10% heat-
inactivated fetal bovine serum, and primed with 25 ng/ml
lipopolysaccharide (LPS, Escherichia coli 0111:B4, Sigma)
for three hours. After the supernatant was replaced by
fresh medium or Opti-MEM, cells were stimulated with
1.5 mM adenosine triphosphate (ATP) for one hour,
then the supernatants were assayed for IL-1β ELISA or
Western blotting, respectively. In addition, whole cell ex-
tracts were prepared with ice-cold W buffer (20 mM
HEPES-KOH, 10 mM KCl, 1.5 mM MgCl2, 1 mM Na-
EDTA, 1 mM Na-EGTA, 0.1 mM PMSF and protease
inhibitor cocktail (Sigma), pH 7.5) and solubilized by a
sonicator [8]. The cell lysates were clarified by centrifuga-
tion for 10 minutes at 16,000 g and incubated overnight at
4°C with anti-NLRP3 antibody. The reaction mixtures
were then incubated for 60 minutes at 4°C with protein
G-Sepharose to precipitate the antigen-antibody com-
plexes. The precipitates were washed five times with W
buffer and subjected to Western blotting analysis.RNAi knockdown of CARD8
Human monocytes were isolated from peripheral blood
cells using RosetteSep (Stemcell Technologies, Vancouver,
BC, Canada). Human monocyte-derived macrophages
(HMDMs) were differentiated after incubation of the
monocytes for seven days in RPMI-1640 medium supple-
mented with 10% human serum, 10% heat-inactivated fetal
bovine serum and 50 ng/ml GM-CSF (PeproTech, Rocky
Hill, NJ, USA). The human CARD8-specific siRNA
(siCARD8-1; 5′-CCUCUUAUGCUUCUAAAGUCU-3′
and 5′-ACUUUAGAAGCAUAAGAGGAA-3′) was syn-
thesized by Sigma. Another set of CARD8-specific siRNA
(siCARD8-2; 5′-GAGCCUUUCUAUGCUGUCCUGGAA
A-3′ and 5′-UUUCCAGGACAGCAUAGAAAGGCUC-
3′) and negative control duplex were purchased from Invi-
trogen. HMDMs were transiently transfected with each
siRNA (50 nM) using Lipofectamine RNAiMax (Invitro-
gen). At four days after transfection, knockdown efficiency
was evaluated by real-time quantitative RT-PCR. Then the
cells were primed with 10 ng/ml LPS for three hours
followed by stimulation with 1.5 mM ATP for one hour,
and IL-1β in the culture supernatants was measured by
ELISA. In parallel, ATP-stimulated cells were labeled with
a FAM-YVAD-fmk FLICA caspase-1 assay kit (Immuno-
chemistry, Bloomington, IN, USA), and analyzed by flow
cytometry to evaluate the activity of caspase-1.
Statistical analysis
Student’s unpaired t-tests were performed for statistical
comparisons, and a P-value of less than 0.05 was consid-
ered significant.
Results
Interaction of CARD8 with NLRP3
To study the interactions between CARD8 and NLRP3,
expression plasmid harboring Flag-tagged full length
CARD8, the FIIND domain or the CARD domain of
CARD8 was constructed (Figure 1A). Each expression
plasmid was introduced into HEK293 cells with expres-
sion plasmid of NLRP3 and immunoprecipitated using
anti-Flag antibody. As shown in Figure 1B, full length
CARD8 and the FIIND domain, but not the CARD do-
main were immunoprecipitated with NLRP3, suggesting
that CARD8 interacts with NLRP3 through the FIIND do-
main. To rule out the possibility that the tagging might
affect the results, we carried out similar experiments
using Flag-tagged NLRP3 and CARD8, instead of
NLRP3 and Flag-tagged CARD8, and obtained similar
results (Figure 1C, lane 2).
Next, to study the effect of ASC on the interaction of
NLRP3 with CARD8, ASC expression plasmid was intro-
duced to the cells. The interaction between CARD8 and
NLRP3 was inhibited by the coexpression of ASC in a
dose-dependent manner (lanes 3 to 6). When 100 ng or
Figure 1 Interaction of CARD8 with full length NLRP3. (A) Diagrammatic representation of the dual domain structure of caspase recruitment
domain-containing protein 8 (CARD8). (B) Human Embryonic Kidney (HEK)293 cells were cotransfected with 500 ng each of expression plasmid
for NLRP3 and either CARD8-Flag, function-to-find (FIIND)-Flag, CARD-Flag or an empty vector. At 24 hours after transfection, whole cell lysates
were immunoprecipitated (IP) with anti-Flag antibody and analyzed by Western blotting. The total amount of the plasmid DNA in all transfection
reactions was kept constant by adding the empty vector plasmid. (C) HEK293 cells were transfected with expression plasmids for NLRP3-Flag
(500 ng), CARD8 (500 ng) and apoptosis-associated speck-like protein containing a CARD (ASC) (10, 30, 100 or 300 ng), and analyzed as above.
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Figure 2 Suppression of NLRP3 inflammasome by expression of
CARD8. (A) Human Embryonic Kidney (HEK)293 cells were
transfected with expression plasmids for proIL-1β (200 ng), NLRP3
(50 ng), procaspse-1 (10 ng), apoptosis-associated speck-like protein
containing a CARD (ASC) (25 ng) and either caspase recruitment
domain-containing protein 8 (CARD8)-Flag, function-to-find (FIIND)-Flag,
CARD-Flag or empty vector (100 ng each). At 24 hours after transfection,
the supernatants were replaced by fresh medium and incubated for
another 24 hours; thereafter, the second supernatants were subjected to
ELISA. Each column represents the mean ± SD (n = 4), **P <0.005, and
***P <0.001 vs. no CARD8 component. (B) HEK293 cells were transfected
with the same set of plasmids as A. A total of 24 hours after transfection,
or after a further two-hour incubation in serum-free medium, cell lysates
(Lys) or supernatants (Sup), respectively, were analyzed by Western
blotting.
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fected, NLRP3 was coprecipitated with ASC rather than
with CARD8 (lanes 5 to 7). Thus, the interaction of ASC
with NLRP3 seemed to be stronger than that of CARD8
with NLRP3 in this condition.
Suppression of NLRP3 inflammasome by expression
of CARD8
When HEK293 cells were transfected with every inflam-
masome component, that is, NLRP3, ASC, procaspase-1
and proIL-1β, large amounts of IL-1β were secreted
spontaneously. To examine the effect of CARD8 on acti-
vation of the NLRP3 inflammasome, the expression con-
struct of CARD8 was cotransfected, which resulted in
significant reduction of IL-1β secretion (Figure 2A). The
FIIND domain and the CARD domain also inhibited IL-
1β secretion suggesting that not only the CARD8-
procaspase-1-interaction as shown by other investigators
[13], but also the CARD8-NLRP3-interaction contributes
to the reduction of IL-1β secretion. In this experiment,
production of IL-1β and expression of inflammasome
components were confirmed by Western blot (Figure 2B).
Suppression of NLRP3-speck formation by CARD8
ASC is known to recruit NLRP3 and caspase-1 to form a
speck-like assembly of the proteins [6,21,22]. To examine
the effect of CARD8 on speck formation in the presence of
ASC, NLRP3 and procaspase-1, fluorescent fusion proteins
were expressed in HEK293 cells. After transfection, we ob-
served GFP and DsRed in more than half of the cells. In
representative microscopic fields, NLRP3-GFP was local-
ized in the cytoplasm, while CARD8-DsRed was localized
in both the nucleus and cytoplasm (Figure 3A, upper
panel). When ASC was co-expressed in the cell, NLRP3-
GFP formed speck-like aggregates, while CARD8-DsRed
did not (Figure 3A, lower panel). CARD8-GFP and
procaspase-1-DsRed were localized in both the nucleus and
cytoplasm in the absence of ASC (Figure 3B, upper panel).
Coexpression of ASC induced speck-like aggregates con-
taining procaspase-1-DsRed, but not CARD8-GFP, in the
cytoplasm (Figure 3B, lower panel). ASC-included speck-
like aggregates were confirmed to contain NLRP3-GFP and
procaspase-1-DsRed (Figure 3C, lower panel). These results
suggest that overexpression of ASC recruits both NLRP3
and procaspase-1 to form the inflammasome, which does
not contain CARD8.
Next, to investigate the role of CARD8, the number of
speck-positive cells in the expression of different dosages of
CARD8 was counted. When cells were transfected with
NLRP3-GFP, ASC, procaspase-1 and proIL-1β, the percent-
age of NLRP3-speck positive cells was 27.1 ± 2.9% (mean ±
SD). However, the number of speck positive cells was re-
duced by coexpression of CARD8 in a dose-dependent
manner (Figure 3D). Transfection of ASC alone has beenknown to form speck [23,24], but coexpression of CARD8
had no effect on the number of ASC-speck positive cells
(data not shown). These results suggest that CARD8 nega-
tively regulates formation of NLRP3 inflammasome, al-
though the final product of the inflammasome does not
Figure 3 Suppression of NLRP3-speck formation by CARD8. (A) Human Embryonic Kidney (HEK)293 cells were cotransfected with expression
plasmid constructs of NLRP3-GFP, caspase recruitment domain-containing protein 8 (CARD8)-DsRed, procaspase-1, and either apoptosis-associated
speck-like protein containing a CARD (ASC) or an empty vector. After 24 hours, green and red fluorescent signals were detected by a confocal laser
scanning microscope. The scale bar represents 10 μm. (B) The same as A except for using NLRP3, CARD8-GFP and procaspase-1-DsRed. (C) The same
as A, except for using NLRP3-GFP, CARD8 and procaspase-1-DsRed. (D) HEK293 cells were cotransfected with expression plasmids for NLRP3-GFP
(30 ng), ASC (5 ng), procaspase-1 (2.5 ng), proIL-1β (30 ng) and CARD8 (5, 15, 50, 150 or 500 ng) or an empty vector. At 24 hours after transfection, the
percentage of NLRP3-GFP-speck positive cells in the transfected cells was determined. Data represent the mean ± SD (n = 9).
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CARD8 leads to a reduced amount of inflammasome for-
mation, and this results in a reduced amount of IL-1β se-
cretion by the cells than those without CARD8 expression.
No interaction between CARD8 and CAPS-associated
NLRP3 mutants
To test the interaction of CARD8 with CAPS-associated
NLRP3 mutants, we engineered NLRP3 expression plas-
mids containing the mutations found in CAPS patients.
The missense mutation of R260W was reported in
FCAS and MWS, D303N in MWS and CINCA, and
N477K in CINCA [25]. H312P is a rare mutation which
was first found in a patient with MWS in our hospital
[26] (Figure 4A). In the absence of ASC, wild type
NLRP3-Flag was precipitated with CARD8 (Figure 4B,
lane 2). In contrast, Flag-tagged NLRP3 with R260W,
D303N or H312P mutation failed to bind to CARD8
(lanes 3 to 5). Similar results were observed when we
carried out the experiments using CARD8-Flag and
NLRP3, instead of CARD8 and NLRP3-Flag (Figure 4C).
To study whether the effect of CARD8 on the inflamma-
some is different between the inflammasome containing
wild type NLRP3 and mutant NLRP3, we compared the
IL-1β concentration in the culture medium (Figure 4D).
IL-1β secretion from the cells transfected with wild type
NLRP3 was significantly inhibited by the coexpression of
CARD8, which was consistent with the results shown inFigure 2. In contrast, CARD8 did not inhibit IL-1β secre-
tion from the cells transfected with mutant NLRP3 in any
of the cases we tested.
Interaction of endogenous CARD8 and NLRP3
Apart from the transfected cells, we were interested in
examining the interaction between endogenous CARD8
and NLRP3. The CARD8 gene is known to have a single
nucleotide polymorphism (rs2043211) that results in an
A > T transversion. Genotype A/A expresses the T48 iso-
form, and genotype T/T expresses the T47 isoform in
which the first 25 amino acids at the N-terminus of T48
are replaced by an alternative 20 amino acids [27]. The
majority (approximately 90%) of the population in
Germany, Hungary and the Netherlands are reported to
have the T48 isoform [28]. In monocytes and macro-
phages, it is known that LPS priming induces proIL-1β
synthesis, and the following ATP stimulation activates
NLRP3 via the P2X7 receptor [29,30]. The interaction be-
tween endogenous CARD8 and NLRP3 was tested using
the PBMCs of healthy volunteers. In the resting state,
NLRP3 was precipitated with CARD8, but not with ASC
(Figure 5A). When cells were primed with LPS followed
by ATP stimulation, however, NLRP3 was precipitated
with ASC instead of CARD8 (Figure 5A), and high
amounts of IL-1β were secreted into the culture medium
(Figure 5B, C). Similar results were observed in the T48
and T47 isoforms.
Figure 4 (See legend on next page.)
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Figure 4 CARD8 fails to bind CAPS-associated NLRP3 mutants. (A) Diagrammatic representation of the three-domain structure of NLRP3 with
asterisks indicating the location of mutations. (B) Human Embryonic Kidney (HEK)293 cells were transfected with expression plasmids (500 ng each)
for NLRP3-Flag (wild type (WT), R260W, D303N or H312P) and caspase recruitment domain-containing protein 8 (CARD8) with or without
apoptosis-associated speck-like protein containing a CARD (ASC) (300 ng). At 24 hours after transfection, expression of each protein (Input) was
confirmed by Western blotting. Simultaneously, the whole cell lysates were the immunoprecipitated (IP) with anti-Flag antibody and analyzed by
Western blotting. (C) Similar experiments as above were carried out, but CARD8 was Flag-tagged in place of NLRP3. (D) HEK293 cells were transfected
with expression plasmids of proIL-1β (200 ng), NLRP3 (WT, R260W, D303N, H312P or N477K) (50 ng), procaspase-1 (10 ng), ASC (25 ng) and CARD8 or
an empty vector (100 ng). At 24 hours after transfection, the supernatants were replaced by fresh medium and incubated for another 24 hours;
thereafter, the second supernatants were subjected to ELISA and pellets were analyzed by Western blotting. Levels of IL-1β secretion from transfectants
were expressed as a relative percentage compared with those from cells with each NLRP3 without CARD8. Each column represents the mean ± SD
(n = 3), ***P <0.001 vs. no CARD8. NS, not significant vs. no CARD8.
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CARD8-knockdown
To define the suppressive effect of endogenous CARD8 on
NLRP3 inflammasome, CARD8 was knocked down in
HMDMs and ATP-induced IL-1β secretion was measured.
By transfection of CARD8-specific siRNA (siCARD8-1 or
siCARD8-2), expression of CARD8 mRNA was signifi-
cantly suppressed (Figure 6A). When these HMDMs wereFigure 5 Endogenous CARD8 interacts with NLRP3 irrespective of the
from healthy volunteers with the T48 isoform or T47 isoform before and after
(ATP) were analyzed by immunoprecipitation (IP) and Western blotting. IC: iso
stimulated as in A was measured by ELISA. Each column represents the mean
from the cells stimulated as in A was analyzed by Western blotting. CARD8, castimulated with LPS and ATP, CARD8-knockdown
HMDMs secreted higher amounts of IL-1β than those
transfected with control RNA (Figure 6B). Accordingly, in
the flow cytometric analysis of the caspase-1 activity, the
number of activated-caspase-1 positive cells as well as
their mean fluorescence intensity was higher in the
CARD8-knockdown HMDMs than those transfected with
the control RNA (Figure 6C).isoform. (A) Cell lysates of peripheral blood mononuclear cells (PBMCs)
stimulation by lipopolysaccharide (LPS) and adenosine triphosphate
type-matched control antibody. (B) IL-1β in supernatants from cells
± SD (n = 4), ***P <0.001. (C) IL-1β in lysates (Lys) and supernatants (Sup)
spase recruitment domain-containing protein 8.
Figure 6 CARD8-knockdown facilitates ATP-induced IL-1β secretion. (A) Caspase recruitment domain-containing protein 8 (CARD8) targeting
(siCARD8-1, siCARD8-2) or control (siCon) RNA (50 nM) was transfected in human monocyte-derived macrophages (HMDMs). After stimulation of
the cells with lipopolysaccharide (LPS), efficiency of the knockdown was evaluated by qPCR. (B) CARD8-knockdown HMDMs were stimulated with
LPS and adenosine triphosphate (ATP), and secreted IL-1β was measured by ELISA. (C) CARD8-knockdown HMDMs were stimulated with LPS and
ATP, and activation of caspase-1 was determined by flow cytometry using a fluorescence-labeled irreversible caspase-1 substrate (FLICA). The data
shown are representative of three independent experiments with similar results. Each column represents the mean ± SD (n = 4), ***P <0.001.
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In the present study, we obtained four major findings: 1)
in the HEK293 cell expression system, CARD8 interacted
with wild-type NLRP3 but not with CAPS-associated mu-
tant NLRP3; 2) CARD8 suppressed IL-1β secretion from
the cells transfected with wild-type NLRP3, but not from
the cells with CAPS-associated mutant NLRP3; 3) in
PBMCs from healthy subjects, endogenous NLRP3 inter-
acted with CARD8 in a resting state, but the partner chan-
ged to ASC after stimulation by LPS and ATP; and finally,
4) in HMDMs from healthy subjects, ATP-stimulated IL-
1β secretion was increased by knockdown of CARD8.
Using HEK293T cells and calcium phosphate transfec-
tion methods, it has been reported that VSV-tagged
CARD8 interacts with Flag-tagged truncated NLRP3
(ΔLRRs), but no interaction was detected between VSV-
tagged CARD8 and Flag-tagged full-length NLRP3 [3].In our experiments, however, CARD8 interacted with full
length NLRP3. Differences in tagging, cells, culture
medium and transfection methods may produce different
results. We were cautious, therefore, and experiments
using Flag-tagged NLRP3 were repeated using Flag-tagged
CARD8, with similar results. Furthermore, we confirmed
the interaction between endogenous CARD8 and NLRP3
in normal PBMCs. In the transfection study with HEK293
cells, NLRP3 did interact with CARD8, but ASC prevented
the interaction in a dose-dependent manner. Moreover,
HEK293 cells transfected with every component of NLRP3
inflammasome spontaneously showed speck formation and
produced IL-1β. These results suggest that gene transfer it-
self may induce conversion of NLRP3 to activated form, to
which CARD8 does not bind. Consistent with this hypoth-
esis, endogenous NLRP3 interacted with CARD8 in PBMCs
only in a resting state; after stimulation with LPS and ATP,
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may hold NLRP3 in an inactive form until the cells encoun-
ter stimuli over a threshold level.
Families of small proteins that are called CARD-only pro-
teins (COPs) and PYD-only proteins (POPs) have recently
been known to negatively regulate inflammasome and sup-
press spontaneous or unnecessary activation by playing a
role as decoy partners [31-33]. Similar to COPs, the CARD
domain of CARD8 is reported to interact with the CARD
domain of procaspase-1; these CARD domains are highly
homologous to each other, resulting in suppression of auto-
cleavage of procaspase-1 [13]. In the present study, IL-1β
secretion was reduced in HEK293 cells transfected with
every inflammasome component, by coexpression of the
FIIND domain of CARD8, suggesting that this domain is
also responsible for negative regulation of NLRP3 inflamma-
some by inhibiting NLRP3 oligomerization. Furthermore,
CARD8-knockdown HMDMs secreted a significantly higher
amount of IL-1β along with caspase-1 activation, suggesting
that CARD8 plays a role as a negative regulator on the en-
dogenous NLRP3 inflammasome as well. How much the
suppressive effect of CARD8 on IL-1β secretion resulted
from the interaction with NLRP3 independent of that with
procaspase-1 remains to be elucidated. Analogous to this
hypothesis, CARD8 has been recently reported to interact
with the NOD domain of NOD2, which is one of the NLR
family members, and inhibits nodosome assembly [34].
We also examined interaction of CARD8 and CAPS-
associated NLRP3 mutants, but no significant interaction
was detected with any mutants tested. This may result
from a change of the local structure by replacement of an
amino acid in the NOD domain that is normally the bind-
ing site for CARD8. As a result, CARD8 did not reduce IL-
1β secretion by inflammasome containing mutant NLRP3.
These results suggest that CAPS-associated mutant NLRP3
escapes the CARD8 restriction, which might be responsible
for unnecessary activation of NLRP3 inflammasome in the
patients.
Conclusion
Our data support the model of NLRP3 inflammasome
excluding CARD8. Until specific stimuli activate NLRP3,
CARD8 holds NLRP3, and is supposed to prevent activa-
tion by subtle stimuli. Because CAPS-associated mutant
NLRP3 is not protected by CARD8, it may form inflam-
masome without obvious stimulation.
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